{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T19:28:02Z","timestamp":1757618882799,"version":"3.44.0"},"reference-count":10,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2025,7,14]],"date-time":"2025-07-14T00:00:00Z","timestamp":1752451200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,7,14]],"date-time":"2025-07-14T00:00:00Z","timestamp":1752451200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Endocrinol"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1038\/s41574-025-01151-7","type":"journal-article","created":{"date-parts":[[2025,7,14]],"date-time":"2025-07-14T09:41:03Z","timestamp":1752486063000},"page":"518-520","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Can obesity pharmacotherapy be used to manage male infertility?"],"prefix":"10.1038","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3353-1863","authenticated-orcid":false,"given":"Amy E.","family":"Morrison","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dimitris","family":"Papamargaritis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2578-8223","authenticated-orcid":false,"given":"Channa N.","family":"Jayasena","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Neelam","family":"Potdar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Yates","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gregory J. H.","family":"Biddle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-8483-8197","authenticated-orcid":false,"given":"Malak","family":"Hamza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9987-9371","authenticated-orcid":false,"given":"Melanie J.","family":"Davies","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Narendra L.","family":"Reddy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,7,14]]},"reference":[{"key":"1151_CR1","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.ecl.2021.11.009","volume":"51","author":"N Papanikolaou","year":"2022","unstructured":"Papanikolaou, N., Luo, R. & Jayasena, C. N. Fertility considerations in hypogonadal men. Endocrinol. Metab. Clin. North Am 51, 133\u2013148 (2022).","journal-title":"Endocrinol. Metab. Clin. North Am"},{"key":"1151_CR2","doi-asserted-by":"publisher","first-page":"563","DOI":"10.14310\/horm.2002.1621","volume":"14","author":"TJG Chambers","year":"2015","unstructured":"Chambers, T. J. G. & Richard, R. A. The impact of obesity on male fertility. Hormones 14, 563\u2013568 (2015).","journal-title":"Hormones"},{"key":"1151_CR3","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1111\/andr.13552","volume":"13","author":"G Venigalla","year":"2025","unstructured":"Venigalla, G. et al. Male obesity: associated effects on fertility and the outcomes of offspring. Andrology 13, 64\u201371 (2025).","journal-title":"Andrology"},{"key":"1151_CR4","doi-asserted-by":"publisher","first-page":"1414","DOI":"10.1093\/humrep\/deac096","volume":"37","author":"E Andersen","year":"2022","unstructured":"Andersen, E. et al. Sperm count is increased by diet-induced weight loss and maintained by exercise or GLP-1 analogue treatment: a randomized controlled trial. Hum. Reprod. 37, 1414\u20131422 (2022).","journal-title":"Hum. Reprod."},{"key":"1151_CR5","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1210\/clinem\/dgad523","volume":"109","author":"A Sharma","year":"2024","unstructured":"Sharma, A. et al. Improvements in sperm motility following low- or high-intensity dietary interventions in men with obesity. J. Clin. Endocrinol. Metab. 109, 449\u2013460 (2024).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"1151_CR6","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1038\/s41366-024-01473-y","volume":"49","author":"E Melson","year":"2025","unstructured":"Melson, E., Ashraf, U., Papamargaritis, D. & Davies, M. J. What is the pipeline for future medications for obesity? Int. J. Obes. 49, 433\u2013451 (2025).","journal-title":"Int. J. Obes."},{"key":"1151_CR7","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1016\/j.soard.2019.04.019","volume":"15","author":"C Carette","year":"2019","unstructured":"Carette, C. et al. Changes in total sperm count after gastric bypass and sleeve gastrectomy: the BARIASPERM prospective study. Surg. Obes. Relat. Dis. 15, 1271\u20131279 (2019).","journal-title":"Surg. Obes. Relat. Dis."},{"key":"1151_CR8","doi-asserted-by":"publisher","first-page":"1499","DOI":"10.1111\/andr.13015","volume":"9","author":"R Cannarella","year":"2021","unstructured":"Cannarella, R. et al. Is there a role for glucagon-like peptide-1 receptor agonists in the treatment of male infertility? Andrology 9, 1499\u20131503 (2021).","journal-title":"Andrology"},{"key":"1151_CR9","doi-asserted-by":"publisher","first-page":"672","DOI":"10.3390\/jcm12020672","volume":"12","author":"S La Vignera","year":"2023","unstructured":"La Vignera, S., Condorelli, R. A., Calogero, A. E., Cannarella, R. & Aversa, A. Sexual and reproductive outcomes in obese fertile men with functional hypogonadism after treatment with liraglutide: preliminary results. J. Clin. Med. 12, 672 (2023).","journal-title":"J. Clin. Med."},{"key":"1151_CR10","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1111\/dom.16042","volume":"27","author":"N Gregori\u010d","year":"2025","unstructured":"Gregori\u010d, N., \u0160ikonja, J., Jane\u017e, A. & Jensterle, M. Semaglutide improved sperm morphology in obese men with type 2 diabetes mellitus and functional hypogonadism. Diabetes Obes. Metab. 27, 519\u2013528 (2025).","journal-title":"Diabetes Obes. Metab."}],"container-title":["Nature Reviews Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41574-025-01151-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41574-025-01151-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41574-025-01151-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,7]],"date-time":"2025-09-07T08:47:45Z","timestamp":1757234865000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41574-025-01151-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,14]]},"references-count":10,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["1151"],"URL":"https:\/\/doi.org\/10.1038\/s41574-025-01151-7","relation":{},"ISSN":["1759-5029","1759-5037"],"issn-type":[{"type":"print","value":"1759-5029"},{"type":"electronic","value":"1759-5037"}],"subject":[],"published":{"date-parts":[[2025,7,14]]},"assertion":[{"value":"14 July 2025","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"D.P. has received honoraria for lectures from Novo Nordisk, Eli Lilly, Boehringer Ingelheim and Johnson and Johnson and has received research grants from Novo Nordisk, Novo Nordisk UK Research Foundation and Academy of Medical Sciences\/Diabetes UK. C.N.J. received research-led grants from Logixx Pharma. T.Y. is supported by the NIHR Leicester BRC and has received funding from Astra Zeneca for an investigator-initiated project. M.J.D. has acted as a consultant\/advisor and speaker for Eli Lilly, Novo Nordisk and Sanofi, has attended advisory boards for Amgen, AstraZeneca, Biomea Fusion, Carmot\/Roche, Sanofi, Zealand Pharma and Regeneron and has acted as a speaker for AstraZeneca and Boehringer Ingelheim. M.J.D. has received grants from AstraZeneca, Boehringer Ingelheim and Novo Nordisk. The other authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}